NCT01499225 - A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2013

Conditions

Chronic Periodontitis

Interventions

DRUG

YH14642 500mg Tab

YH14642 500mg per day(once a day)

DRUG

YH14642 500mg Tab

YH14642 1000mg per day(twice a day)

DRUG

YH14642 500mg Tab

YH14642 2000mg per day(three times a day)

DRUG

INSADOL[Zea mays L. extract] 35mg Tab

"\[Initiation dose : 4weeks after administraion\] INSADOL\[Zea mays L. extract\] 210mg TAB per day~\[Maintain dose : Between 4weeks and 8weeks after administraion\] INSADOL\[Zea mays L. extract\] 105mg TAB per day~\[Maintain dose : Between 8weeks and 12weeks after administraion\] INSADOL\[Zea mays L. extract\] 105mg TAB per day"

DRUG

DENTISTA[Doxycycline hyclate] 20mg Cap

DENTISTA\[Doxycycline hyclate\] Cap 40mg per day

DRUG

Placebo

Trial Locations (1)

Unknown

Seoul National University Dental Hospital, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY